MedFriend Ltd is pleased to be attending PCMG, bringing together leaders from across clinical operations, outsourcing, procurement, vendor management and pharmaceutical development.

For MedFriend, PCMG represents an important opportunity to engage with the conversations shaping the future of clinical development, from CRO selection and outsourcing strategy to procurement transparency, operational efficiency and the evolving role of technology in clinical research.

As a UK-based life sciences consultancy, MedFriend works with pharmaceutical, biotech, clinical research and healthcare organisations to support better decision-making across clinical R&D, vendor selection, market access, digital health and growth strategy.

The themes discussed at PCMG are closely aligned with MedFriend’s work, particularly our focus on helping organisations make more structured, transparent and commercially robust decisions when selecting CROs, vendors and strategic partners.

In parallel, MedFriend is also developing HESKM™, our proprietary CRO procurement software designed to support more transparent, auditable and data-informed vendor selection.

Over the coming days, we will be sharing reflections from PCMG, including insights into the acceleration of clinical development in Asia, the changing role of China in global pharmaceutical innovation, and the future of clinical outsourcing.

To learn more about MedFriend and our work in clinical R&D strategy, CRO selection and procurement support, please contact us at sales@medfriend.health